Simple descriptors and simple rules of the International Ovarian Tumor Analysis (IOTA) Group: a prospective study of combined use for the description of adnexal masses
other
OA: closed
public-domain-us
AI-generated summary
The IOTA group's three-step diagnostic strategy for adnexal masses showed diagnostic performance comparable to expert assessment for nonexpert sonographers.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: External validation of the IOTA group's three-step diagnostic model (Strategy 1) and comparison with assessment by an expert sonographer (Strategy 2).
STUDY DESIGN: Prospective study in patients with persistent adnexal masses, in which an inexperienced sonographer performed transvaginal ultrasound applying simple descriptors (SD) and rules (SR) for classifying as benign or malignant. Any non-classifiable mass was then submitted to an expert examiner for subjective assessment (SA).
RESULTS: Eighty-one patients (mean age, 43; 27.2% postmenopausal) were included in this prospective study. Surgery was performed for 30 (8 malignant and 22 benign) masses; 51 masses were considered as benign and managed expectantly (they were assumed to be benign for statistical purposes). Diagnostic performance for Strategy 1 (SD+SR+SA) was sensitivity (SN): 87.5% (7/8, 95% CI, 47.3-99.7%) and specificity (SP): 100% (73/73, 95% CI, 95.1-100%). For Strategy 2 (SA only) it was SN 87.5% (7/8, 95% CI, 47.3-99.7%), SP 98.6% (72/73, 95% CI, 92.6-100%).
CONCLUSIONS: The three-step diagnostic strategy designed by the IOTA group for adnexal masses has a diagnostic performance comparable to that of subjective expert assessment and could be used as a triage method by nonexpert sonographers.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (26)
- Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study via crossref
- doi:10.1016/j.ajog.2011.01.025 via crossref
- doi:10.1097/gme.0b013e31829be0a0 via crossref
- doi:10.1016/s0140-6736(58)91905-6 via crossref
- doi:10.1016/0002-9378(65)90152-3 via crossref
- doi:10.2214/ajr.141.5.985 via crossref
- doi:10.1006/gyno.1996.0156 via crossref
- doi:10.1016/s0002-9378(96)70257-0 via crossref
- doi:10.1111/j.1471-0528.1990.tb02448.x via crossref
- doi:10.1016/s0002-9378(99)70436-9 via crossref
- doi:10.1067/mob.2003.176 via crossref
- doi:10.1002/uog.6443 via crossref
- doi:10.1016/j.bpobgyn.2003.10.002 via crossref
- doi:10.1046/j.1469-0705.2000.00287.x via crossref
- doi:10.1002/uog.11177 via crossref
- doi:10.1002/uog.5365 via crossref
- doi:10.1136/bmj.c6839 via crossref
- doi:10.1016/j.ygyno.2013.04.003 via crossref
- doi:10.1002/uog.12369 via crossref
- doi:10.1016/j.ygyno.2003.11.029 via crossref
- doi:10.1016/j.ijgo.2008.12.015 via crossref
- doi:10.1002/uog.12308 via crossref
- doi:10.1093/humupd/dmt059 via crossref
- doi:10.1038/bjc.2013.224 via crossref
- doi:10.1002/uog.12440 via crossref
- doi:10.1007/s00404-012-2229-2 via crossref
Source provenance
- crossref
- last seen: 2026-05-16T01:00:09.440997+00:00
- europepmc
- last seen: 2026-06-17T06:13:18.893374+00:00
- pubmed
- last seen: 2026-05-13T22:17:39.907309+00:00
- unpaywall
- last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine